Kuros Biosurgery is a biotechnology company dedicated to developing biomaterials and bioactive biomaterial combination products for indications in trauma, wound and spine. Kuros products are based on two different matrix technologies that allow the attachment of biologics or drugs and that can be applied locally.
Funding Rounds (2) - $9.8MUpdate
Swiss venture capital firm
Swiss PE firm
DEFI Gestion SA has close to CHF 200 million in assets under management, for institutional as...
Genevest provides advisory services for institutional and sophisticated high net worth investors...
CDC Enterprises is a French Government (French treasury) owned â‚¬150 million fund of funds, that...
International venture capital investment
international venture capital firm